News Release
-
11.11.2020 Consolidated Financial Results for the Second Quarter of Fiscal Year 2020
読む Consolidated Financial Results for the Second Quarter of Fiscal Year 2020
-
09.30.2020 Eisai and Seikagaku Enter into Agreement for the Marketing Alliance of SI-613, a Treatment of Osteoarthritis, in South Korea
（363KB）
-
09.24.2020 Seikagaku Announces Forecast of Consolidated Financial Results and Dividend Forecast
（87KB）
読む Seikagaku Announces Forecast of Consolidated Financial Results and Dividend Forecast
-
08.27.2020 Announcement Concerning a COVID-19 Vaccine Development Partnership with VIDO-InterVac at Dalton Chemical Laboratories, Inc.
（127KB）
Seikagaku News Releases are issued to provide stakeholders with the most up-to-date information related to our company.
What's New
-
01.06.2021 Seikagaku will announce the financial results for the Third Quarter of the Fiscal Year ending March 31, 2021 at 15:00 on February 5, 2021.
-
12.02.2020 New Message from President & CEO
-
11.16.2020 Presentation Material for the Briefing on the Second Quater FY2020 Financial Results
読む Presentation Material for the Briefing on the Second Quater FY2020 Financial Results
-
09.30.2020 Seikagaku will announce the financial results for the Second Quarter of the Fiscal Year ending March 31, 2021 at 16:00 on Novermber 11, 2020.
